
We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …

New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a …

A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages …

Stemming from a theory she developed as a sophomore at John Hopkins University in Maryland, Hasini Jayatilaka and a team …

Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …

President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …

More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of …

Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …

Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …

Good news for Novo Nordisk as the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommends that data …

Research emerging from the University of Utah Health has built on knowledge that drugs used in combination can be more …

Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it …

The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …

After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …

A potentially pivotal Phase 1 study has been launched by Pfizer into the use of its investigational vaccine as a …

Angela Merkel was part of the opening ceremony that saw Takeda announce the completion of a third production space in …

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …

A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …

A significant step forward has been made in moving towards a treatment for neglected tropical disease mycetoma as the first-ever …

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …